Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
---|---|---|---|---|---|
11.003.066 | Genetic Testing For Duchenne And Becker Muscular Dystrophy | Apr 17, 2024 | Apr 20, 2025 | Variants in the duchenne muscular dystrophy (dmd) gene, which encodes the protein dystrophin, may result in a... | Ver |
11.003.067 | Genotype-Guided Warfarin Dosing | Jul 08, 2024 | Jul 20, 2025 | Using information about an individual's genotype may help in guiding warfarin dosing and could reduce... | Ver |
11.003.068 | Genetic Testing For The Diagnosis Of Inherited Peripheral Neuropathies | Feb 20, 2025 | Feb 20, 2026 | Description the inherited peripheral neuropathies are a heterogeneous group of diseases that may be inherited... | Ver |
11.003.069 | Analysis Of Mgmt Promoter Methylation In Malignant Gliomas | Jun 13, 2019 | Policy Archived | Testing for o6-methylguanine-dna methyltransferase (mgmt) gene promoter methylation has been proposed as a... | Ver |
11.003.070 | Preimplantation Genetic Testing | Dec 06, 2024 | Sep 20, 2025 | Preimplantation genetic testing involves the analysis of biopsied cells as part of an assisted reproductive... | Ver |
11.003.072 | Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders | Mar 20, 2025 | Mar 20, 2026 | Marfan syndrome (mfs) is a systemic connective tissue disease (ctd) with a high degree of clinical... | Ver |
11.003.073 | Laboratory And Genetic Testing For Use Of 5-Fluorouracil In Patients With Cancer | Apr 15, 2024 | Apr 20, 2025 | Variability in systemic exposure to 5-fluorouracil chemotherapy is thought to directly impact 5-fluorouracil... | Ver |
11.003.075 | Proteomic Testing For Targeted Therapy In Non-Small-Cell Lung Cancer | Dec 06, 2024 | Dec 20, 2025 | Proteomic testing has been proposed as a way to predict survival outcomes, as well as the response to and... | Ver |
11.003.076 | Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis | Jul 19, 2024 | Jul 20, 2025 | Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... | Ver |
11.003.077 | Los ensayos de varios analitos con el análisis algorítmico para predecir el ries | Oct 11, 2016 | Policy Archived | ... | Ver |
11.003.078 | Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna | Feb 03, 2025 | Sep 20, 2025 | National guidelines recommend that all pregnant individuals be offered screening for fetal chromosomal... | Ver |
11.003.079 | Invasive Prenatal (Fetal) Diagnostic Testing | Sep 13, 2024 | Sep 20, 2025 | Invasive prenatal (fetal) diagnostic testing may be used to identify pathogenic genetic alterations in... | Ver |
11.003.081 | Genetic Testing For Macular Degeneration | Apr 18, 2024 | Apr 20, 2025 | Age-related macular degeneration is a complex disease involving both genetic and environmental influences.... | Ver |
11.003.082 | Genetic Testing For Facioscapulohumeral Muscular Dystrophy | Mar 12, 2025 | Mar 20, 2026 | Facioscapulohumeral muscular dystrophy (fshd) is an autosomal dominant disease that typically presents before... | Ver |
11.003.083 | Genetic Testing For Charge Syndrome | Mar 12, 2025 | Mar 20, 2026 | Charge syndrome is a rare genetic condition associated with multiple congenital anomalies. in many... | Ver |
11.003.084 | Genetic Testing For Idiopathic Dilated Cardiomyopathy | Mar 12, 2025 | Mar 20, 2026 | Dilated cardiomyopathy (dcm) is characterized by progressive left ventricular enlargement and systolic... | Ver |
11.003.085 | Genetic Testing For Limb-Girdle Muscular Dystrophies | Jun 18, 2024 | Policy Archived | ... | Ver |
11.003.086 | Kif6 Genotyping For Predicting Cardiovascular Risk | Aug 20, 2021 | Policy Archived | Genetic testing to determine kinesin-like protein 6 (kif6) trp719arg variant status is being evaluated as a... | Ver |
11.003.087 | Molecular Testing In The Management Of Pulmonary Nodules | Jun 18, 2024 | Jun 20, 2025 | Plasma-based proteomic screening and gene expression profiling of bronchial brushing are molecular tests... | Ver |
11.003.088 | Molecular Testing For Chronic Heart Failure And Heart Transplant | Jun 17, 2021 | Policy Archived | Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... | Ver |